J&J applies for EUA with FDA for COVID-19 vaccine
Johnson & Johnson has filed for emergency use authorization
from the FDA for its COVID-19 vaccine after unveiling results from its trial in
January. The company also plans to seek approval from European regulators for
the single-dose vaccine soon.
Full Story: Reuters (2/4)
No comments:
Post a Comment